טוען...
Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients
Higher doses of erythropoiesis-stimulating agents (ESAs) contribute to atherothrombotic cardiovascular disease in hemodialysis (HD) patients. Thrombocytosis is associated with increased mortality in ESA-treated HD patients. We investigated variables affecting platelet count and its variability (plat...
שמור ב:
| הוצא לאור ב: | Int J Nephrol Renovasc Dis |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4822794/ https://ncbi.nlm.nih.gov/pubmed/27099526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S98196 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|